May 3, 2018 / 11:12 AM / in 2 months

BRIEF-AMAG Pharmaceuticals Announces Q1 Loss Per Share $1.59

May 3 (Reuters) - AMAG Pharmaceuticals Inc:

* AMAG PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND RAISES FULL YEAR FINANCIAL GUIDANCE

* Q1 LOSS PER SHARE $1.59

* Q1 REVENUE $146.4 MILLION VERSUS I/B/E/S VIEW $151.8 MILLION

* Q1 EARNINGS PER SHARE VIEW $-0.54 — THOMSON REUTERS I/B/E/S

* AMAG PHARMACEUTICALS - SEES 2018 TOTAL REVENUE $540 MILLION - $580 MILLION

* AMAG PHARMACEUTICALS - SEES 2018 GAAP OPERATING LOSS IN RANGE OF $128 MILLION - $108 MILLION

* AMAG PHARMACEUTICALS - SEES 2018 NON-GAAP ADJUSTED EBITDA $120 MILLION - $140 MILLION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below